THE Therapeutic Goods
Administration is publicising an
urgent consumer-level recall of
Avaira Toric Contact Lenses.
Specific lots of the contact lenses
are being recalled by the sponsor
CooperVision Australia Pty Ltd,
after the company received
complaints of “temporary hazy or
blurry vision and discomfort from
wearers”.
The recall is part of a global
voluntary recall of specific lots of
the product, after laboratory tests
found the symptoms were caused
by a small amount of residue on
the lenses.
In all reported cases so far the
symptoms were temporary and
reversed after the contact lenses
were removed, with no reports of
permanent eye damage.
The CooperVision website at
www.coopervision.com has details
of the specific lot numbers affected
and consumers concerned about
the products can also call the
company’s customer service line on
1800 722 310.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 11
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.